You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 2, February 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Desipramine Facilitation of Initial Cocaine Abstinence

Frank H. Gawin, MD; Herbert D. Kleber, MD; Robert Byck, MD; Bruce J. Rounsaville, MD; Thomas R. Kosten, MD; Peter I. Jatlow, MD; Cynthia Morgan

Arch Gen Psychiatry. 1989;46(2):117-121.


Abstract

• We conducted a double-blind, random assignment, six-week comparison of desipramine hydrochloride (n = 24), lithium carbonate (n = 24), and placebo (n = 24) treatments for cocaine dependence. Subjects were 72 outpatient cocaine abusers who met DSM-III-R dependence criteria for cocaine but not for other substance abuse. Subjects in each treatment group were similar in history of cocaine and other substance abuse, cocaine craving, sociodemographics, and other psychiatric comorbidity. Desipramine, compared with both other treatments, substantially decreased cocaine use. Lithium treatment outcome did not differ from that of placebo. Desipramine-treated subjects attained contiguous periods of abstinence substantially more frequently than subjects receiving lithium or placebo. Fifty-nine percent of the desipramine-treated subjects were abstinent for at least three to four consecutive weeks during the six-week study period, compared with 17% for placebo and 25% for lithium. Cocaine craving reductions were also substantially greater in the desipraminetreated subjects. Establishment of initial abstinence is the first stage in recovery from cocaine dependence. Our findings indicate that desipramine is an effective general treatment, for this first treatment stage, in actively cocaine-dependent oupatients.



Author Affiliations

From the Departments of Psychiatry (Drs Gawin, Kleber, Byck, Rounsaville, Kosten, and Jatlow and Ms Morgan), Pharmacology (Dr Byck), and Laboratory Medicine (Dr Jatlow), School of Medicine, Yale University, and the APT Foundation (Drs Gawin, Kleber, Rounsaville, and Kosten and Ms Morgan), New Haven, Conn.


Footnotes

Accepted for publication Oct 27, 1988.

Reprint requests to the Department of Psychiatry, Yale University School of Medicine, 34 Park St, New Haven, CT 06510 (Dr Gawin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

References
APPI Online CME 2007;2007:2-2.
FULL TEXT  

Variation in Neurophysiological Function and Evidence of Quantitative Electroencephalogram Discordance: Predicting Cocaine-Dependent Treatment Attrition
Venneman et al.
J. Neuropsychiatry Clin. Neurosi. 2006;18:208-216.
ABSTRACT | FULL TEXT  

Six-Month Trial of Bupropion With Contingency Management for Cocaine Dependence in a Methadone-Maintained Population
Poling et al.
Arch Gen Psychiatry 2006;63:219-228.
ABSTRACT | FULL TEXT  

Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
Lingford-Hughes et al.
J Psychopharmacol 2004;18:293-335.
 

Phospholipase C{gamma} in Distinct Regions of the Ventral Tegmental Area Differentially Modulates Mood-Related Behaviors
Bolanos et al.
J. Neurosci. 2003;23:7569-7576.
ABSTRACT | FULL TEXT  

The Relationship Between Cocaine Craving, Psychosocial Treatment, and Subsequent Cocaine Use
Weiss et al.
Am. J. Psychiatry 2003;160:1320-1325.
ABSTRACT | FULL TEXT  

Stress-Induced Suppression of the Immune System after Withdrawal from Chronic Cocaine
Avila et al.
J. Pharmacol. Exp. Ther. 2003;305:290-297.
ABSTRACT | FULL TEXT  

Antidepressant-Like Effects of kappa -Opioid Receptor Antagonists in the Forced Swim Test in Rats
Mague et al.
J. Pharmacol. Exp. Ther. 2003;305:323-330.
ABSTRACT | FULL TEXT  

Cocaine-primed craving and its relationship to depressive symptomatology in individuals with cocaine dependence
Elman et al.
J Psychopharmacol 2002;16:163-167.
ABSTRACT  

Altered Responsiveness to Cocaine and Increased Immobility in the Forced Swim Test Associated with Elevated cAMP Response Element-Binding Protein Expression in Nucleus Accumbens
Pliakas et al.
J. Neurosci. 2001;21:7397-7403.
ABSTRACT | FULL TEXT  

Alcohol & Drug Abuse: Practical Guidelines for the Treatment of Substance Abusers With Adult Attention-Deficit Hyperactivity Disorder
Levin et al.
Psychiatr. Serv. 1999;50:1001-1003.
FULL TEXT  

Psychosocial Treatments for Cocaine Dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study
Crits-Christoph et al.
Arch Gen Psychiatry 1999;56:493-502.
ABSTRACT | FULL TEXT  

Characteristics of Drug Interactions with Recombinant Biogenic Amine Transporters Expressed in the Same Cell Type
Eshleman et al.
J. Pharmacol. Exp. Ther. 1999;289:877-885.
ABSTRACT | FULL TEXT  

Antidepressant Prescribing Practices of Outpatient Psychiatrists
Olfson et al.
Arch Gen Psychiatry 1998;55:310-316.
ABSTRACT | FULL TEXT  

Imipramine Treatment of Opiate-Dependent Patients With Depressive Disorders: A Placebo-Controlled Trial
Nunes et al.
Arch Gen Psychiatry 1998;55:153-160.
ABSTRACT | FULL TEXT  

Sustained Cocaine Abstinence in Methadone Maintenance Patients Through Voucher-Based Reinforcement Therapy
Silverman et al.
Arch Gen Psychiatry 1996;53:409-415.
ABSTRACT  

Management of Cocaine Abuse and Dependence
Mendelson and Mello
NEJM 1996;334:965-972.
FULL TEXT  

One-Year Follow-up of Psychotherapy and Pharmacotherapy for Cocaine Dependence: Delayed Emergence of Psychotherapy Effects
Carroll et al.
Arch Gen Psychiatry 1994;51:989-997.
ABSTRACT  

Noradrenergic Dysregulation During Discontinuation of Cocaine Use in Addicts
McDougle et al.
Arch Gen Psychiatry 1994;51:713-719.
ABSTRACT  

Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence
Higgins et al.
Arch Gen Psychiatry 1994;51:568-576.
ABSTRACT  

Psychotherapy and Pharmacotherapy for Ambulatory Cocaine Abusers
Carroll et al.
Arch Gen Psychiatry 1994;51:177-187.
ABSTRACT  

Antibody-catalyzed degradation of cocaine
Landry et al.
Science 1993;259:1899-1901.
ABSTRACT  

Pharmacotherapy for Cocaine-Abusing Methadone-Maintained Patients Using Amantadine or Desipramine
Kosten et al.
Arch Gen Psychiatry 1992;49:894-898.
ABSTRACT  

New Pharmacotherapies for Cocaine Dependence... Revisited
Meyer
Arch Gen Psychiatry 1992;49:900-904.
ABSTRACT  

Contrast of Treatment-Seeking and Untreated Cocaine Abusers
Carroll and Rounsaville
Arch Gen Psychiatry 1992;49:464-471.
ABSTRACT  

Substance Abuse
Frances
JAMA 1991;265:3171-3172.
ABSTRACT  

Cocaine addiction: psychology and neurophysiology
Gawin
Science 1991;251:1580-1586.
ABSTRACT  

Psychiatric Diagnoses of Treatment-Seeking Cocaine Abusers
Rounsaville et al.
Arch Gen Psychiatry 1991;48:43-51.
ABSTRACT  

Hooked on Hormones? An Anabolic Steroid Addiction Hypothesis
Kashkin and Kleber
JAMA 1989;262:3166-3170.
ABSTRACT  

Outpatient Treatment of 'Crack' Cocaine Smoking With Flupenthixol Decanoate: A Preliminary Report
Gawin et al.
Arch Gen Psychiatry 1989;46:322-325.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.